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Abstract
Amongmetallo-dependent phosphatases, ADP-ribose/CDP-alcohol diphosphatases form a
protein family (ADPRibase-Mn-like) mainly restricted, in eukaryotes, to vertebrates and
plants, with preferential expression, at least in rodents, in immune cells. Rat and zebrafish
ADPRibase-Mn, the only biochemically studied, are phosphohydrolases of ADP-ribose and,
somewhat less efficiently, of CDP-alcohols and 2´,3´-cAMP. Furthermore, the rat but not the
zebrafish enzyme displays a unique phosphohydrolytic activity on cyclic ADP-ribose. The
molecular basis of such specificity is unknown. Human ADPRibase-Mn showed similar activ-
ities, including cyclic ADP-ribose phosphohydrolase, which seems thus common to mamma-
lian ADPRibase-Mn. Substrate docking on a homology model of human ADPRibase-Mn
suggested possible interactions of ADP-ribose with seven residues located, with one excep-
tion (Cys253), either within the metallo-dependent phosphatases signature (Gln27, Asn110,
His111), or in unique structural regions of the ADPRibase-Mn family: s2s3 (Phe37 and Arg43)
and h7h8 (Phe210), around the active site entrance. Mutants were constructed, and kinetic
parameters for ADP-ribose, CDP-choline, 2´,3´-cAMP and cyclic ADP-ribose were deter-
mined. Phe37 was needed for ADP-ribose preference without catalytic effect, as indicated by
the increased ADP-ribose Km and unchanged kcat of F37A-ADPRibase-Mn, while the Km val-
ues for the other substrates were little affected. Arg43 was essential for catalysis as indicated
by the drastic efficiency loss shown by R43A-ADPRibase-Mn. Unexpectedly, Cys253 was
hindering for cADPR phosphohydrolase, as indicated by the specific tenfold gain of efficiency
of C253A-ADPRibase-Mn with cyclic ADP-ribose. This allowed the design of a triple mutant
(F37A+L196F+C253A) for which cyclic ADP-ribose was the best substrate, with a catalytic
efficiency of 3.5´104 M-1s-1 versus 4´103 M-1s-1 of the wild type.
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Introduction
The Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase (ADPRibase-Mn; EC 3.6.1.53)
is one of several enzymes known in mammals to hydrolyze with some degree of specificity the
phosphoanhydride linkage of ADP-ribose and other nucleoside diphosphate-X (NDP-X) com-
pounds [1, 2]. Two important peculiarities of ADPRibase-Mn, studied in the rat enzyme, are
its marked preference for Mn2+ over Mg2+ as the activating cation, with a requirement of low
micromolar Mn2+ for activity [1, 2], which is near the physiological level of the metal in animal
cells [3], and its minor but unique activity on the phosphoanhydride linkage of cyclic ADP-ri-
bose (cADPR) [4].
The ADPRibase-Mn substrates ADP-ribose and cADPR are intracellular signal molecules
with known effects on TRPM2 ion channels [5–9] or, in the case of cADPR, on ryanodine re-
ceptors [10–12]. Both are putatively formed, in mammals, from NAD+ by CD38 and Bst-1/
CD157 (reviewed in [13]). The calcium regulator cADPR is an analog of ADP-ribose in which
adenine, besides the standard N9-glycosydic linkage with the C1´ atom of the adenosine moie-
ty, establishes also a N1-glycosydic linkage with the C1´´ atom of the other (‘northern’) ribose,
thus forming a macrocyclic structure [12]. In some animals, like Aplysia, cADPR synthesis is
catalyzed from NAD+ by an ADP-ribosyl cyclase specifically acting as such [14–16], although
in mammals it is synthesized by a quantitatively minor alternative pathway of the NAD glyco-
hydrolases CD38 and Bst-1/CD157, that mainly hydrolyze NAD+ to ADP-ribose. [17–24]. In
mammals, the turnover of cADPR signaling is exerted also by CD38 and Bst-1/CD157, which
convert cADPR to ADP-ribose by hydrolysis of the N1-glycosidic linkage [17–19, 21, 23]. The
diphosphate group of cADPR is resistant to phosphohydrolases of broad specificity [4, 18, 25],
like snake venom phosphodiesterase which otherwise hydrolyzes a large variety of 5´-nucleo-
tide phosphodiester or phosphoanhydride derivatives including e.g. ADP-ribose [26–28]. It is
thus remarkable that rat ADPRibase-Mn acts as cADPR phosphohydrolase with low but signif-
icant efficiency (about 100-fold lower than the activity on ADP-ribose), yielding N1-(5-phos-
phoribosyl)-AMP as the product. This could hypothetically represent a novel route for
cADPR turnover [4]. Interestingly, cADPR and its product of hydrolysis by ADPRibase-Mn,
N1-(5-phosphoribosyl)-AMP, have been identified in a metabolomic profile of human erythro-
cytes infected with Plasmodium falciparum [29]. Also interestingly, in the search for pharma-
cologically-active cADPR analogs [30–33], the previously overlooked possibility of cADPR
phosphohydrolysis is now being taken into account [34–36].
The taxonomic distribution of ADPRibase-Mn is intriguing, as it has been reported to be re-
stricted, among eukaryotes, to vertebrates and plants [2]. Furthermore, biochemical and in-
silico expression data indicate that ADPRibase-Mn is preferentially expressed in immune cells
of rodents [2, 37]. Related to this pattern, it is worth recalling that CD38 and Bst-1/CD157, the
proteins that form ADP-ribose and cADPR, have a regulatory role at the interface between the
innate and the adaptative immune systems [38–41]. In this field there are still some uncomple-
tely solved issues. One is the so-called topological paradox posed by the location of mammalian
proteins forming ADP-ribose and cADPR in the outer surface of plasma membrane, against
the cytosolic action of these compounds. Several explanatory mechanisms for this apparent
paradox have been advanced [12, 42–45]. The intracellular termination of these two signals
and of their effects is also worth of consideration. In addition to ADPRibase-Mn, two mamma-
lian enzymes of the Nudix superfamily are known that can efficiently hydrolyze ADP-ribose
[1, 46–49]. However, for the turnover of cADPR, as stated above, only its conversion to ADP-
ribose by the glycohydrolytic activity of CD38 and Bst-1/CD157, i.e. the same membrane pro-
teins responsible for its synthesis, is generally mentioned. Therefore, it remains to be seen
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whether ADPRibase-Mn could be involved in this regulatory network with a role in the turn-
over of cADPR [4].
ADPRibase-Mn proteins belong to the metallo-dependent phosphatases (MDP) SCOP2 su-
perfamily, within which they form a structural family of their own (ADPRibase-Mn-like; ID
4002589) [50]. In the CATH classification, ADPRibase-Mn proteins form also a unique func-
tional family within the structural cluster SC:2 of superfamily 3.60.21.10 [51]. The only ADPRi-
base-Mn enzymes that have been biochemically studied are those from rat [1, 2, 4] and
zebrafish [52]. The structure of zebrafish ADPRibase-Mn in complex with Pi is deposited in
Protein Data Bank (PDB ID 2NXF), and it has been used as template to construct homology
models of murine and human proteins [53]. Like other MDPs, the putative active site of
ADPRibase-Mn contains a dimetallic center, possibly Fe/Mn, as indicated for the zebrafish
ADPRibase-Mn (http://www.uwstructuralgenomics.org/gallery/2nxf.pdf [54]).
Concerning substrate specificity, ADPRibase-Mn enzymes are Mn2+-dependent ADP-ri-
bose/CDP-alcohol diphosphatases that hydrolyze the phosphoanhydride linkage of ADP-
ribose and, somewhat less efficiently, of CDP-choline, CDP-glycerol and CDP-ethanolamine.
The catalytic efficiency of ADP-ribose hydrolysis, depending on the enzyme source (rat or zeb-
rafish), is 4–60-fold higher than that of CDP-alcohol hydrolysis, and it is a reflection of the low
Km value for ADP-ribose, in spite of the higher kcat shown for CDP-alcohols in every case [2,
52]. Besides the diphosphatase activities on ADP-ribose and CDP-alcohols, ADPRibase-Mn
enzymes display also activity on ADP and 2´,3´-cAMP with similar or lower efficiency than on
CDP-alcohols, and as stated above the rat enzyme is able to hydrolyze the phosphoanhydride
linkage of cADPR. The overall specificity of ADPRibase-Mn enzymes is highlighted by their
lack of significant activity towards ADP-glucose, UDP-glucose, CDP-glucose, CDP, CMP,
AMP or 3´,5´-cAMP [1, 2, 52]. In contrast to the rat enzyme, zebrafish ADPRibase-Mn does
not hydrolyze cADPR significantly, being in this concern at least 150-fold less efficient than
the rat enzyme, while both of them are equally efficient on ADP-ribose [52]. Therefore, it re-
mains to be established whether the cADPR phosphohydrolase activity is a peculiarity of rat
ADPRibase-Mn or may be shared at least by enzymes from other mammalian sources.
The molecular basis of ADPRibase-Mn specificity in terms of interactions between sub-
strates and protein has not been so far investigated by mutagenesis. In the present work, we
have aimed to understand the catalytic behavior of human ADPRibase-Mn by performing an
extensive mutagenesis study based on substrate docking simulations. Important questions are
answered on the molecular basis of the enzyme preference for ADP-ribose and the cADPR
phosphohydrolase activity of mammalian members of the ADPRibase-Mn-like family. Inter-
estingly, a triple mutant of human ADPRibase-Mn acts preferentially as cADPR phosphohy-




The sources of the products used, including cADPR purified from the commercial preparation,
were as described elsewhere [2, 4, 52].
Cloning and sequencing of human ADPRibase-Mn cDNA
The open reading frame (ORF) of human ADPRibase-Mn was cloned from human liver cDNA
(Marathon-Ready cDNA, Clontech) by PCR. The primers were based on the ADPRMmRNA
accession no. NM_020233, which codes for the hypothetical 342-aa protein NP_064618, that is
86% and 51% identical with the biochemically-studied ADPRibase-Mn enzymes from rat
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(ABW03224 [2, 4]) and zebrafish (2NXF_A [52]), respectively. The sequence of the forward
primer was CTAGCGTCGACATGGATGATAAACCCAACCCTGAAGCCC, which includes
a SalI site (single underline) preceding the ORF initiation codon (double underline); and that
of the reverse primer was CAGGTGCGGCCGCCTAACAATGGAATGCTCTTTCTTTC,
which includes a NotI site (single underline) after the stop codon (double underline). The
amplicon was first cloned in pGEM-T Easy vector by T/A ligation and, after identification of a
clone with the expected insert, it was excised and subcloned in frame with the glutathione S-
transferase (GST) tag of the pGEX-6P-3 vector cut with NotI and SalI, yielding plasmid pGEX-
6P-3-hADPRM. The 1029-nt sequence of the human ORF insert was confirmed by double-
strand sequencing (Servicio de Genómica, Instituto de Investigaciones Biomédicas Alberto
Sols, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Ma-
drid) and deposited in GenBank with accession number KF880964. It coincided with the ORF
included in mRNA NM_020233, except for the silent substitutions C18T and A1017C due to
primer design. The theoretical translation of the cloned ORF (accession number AHG56452)
was thus fully identical to the hypothetical 342-aa protein NP_064618.
Site-directed mutagenesis
Point mutants were constructed following the QuikChange protocol (Stratagene) using muta-
genic primer pairs and pGEX-6P-3-hADPRM as template. The double mutants were con-
structed starting from pGEX-6P-3-F37A-hADPRM, and the triple one from pGEX-6P-3-F37A
+L196F-hADPRM. The forward mutagenic primers are shown in S1 Table; the reverse primers
were the exact reverse complement of those. The correctness of all the mutants was confirmed
by double-strand sequencing of the complete coding sequence as above.
Expression and purification of human ADPRibase-Mn protein and its
mutant forms
The wild type and mutant proteins were expressed as fusions with glutathione S-transferase
(GST) from pGEX-6P-3-hADPRM or the corresponding mutated plasmid. The recombinant
proteins were purified by affinity chromatography on glutathione-Sepharose 4B (GE Health-
care), and separated from the GST tag by specific proteolysis with the PreScission protease [2].
This yielded each protein with an 11-amino acid N-terminal extension (GPLGSPNSRVD).
Protein concentration was assayed in the final preparations according to Bradford [55] and the
purity was estimated by SDS-PAGE stained with Coomassie Blue followed by quantitation by
image analysis with the GelAnalyzer 2010 software (http://www.gelanalyzer.com; last access on
December 2, 2014). In all cases, a single major protein band of40.5 kDa, the approximate ex-
pected size for recombinant ADPRibase-Mn and its mutants, was observed. It accounted in the
different preparations for 52%–79% of protein in the gel lanes. The estimations of purity for
each protein are summarized in S2 Table. Since the wild type ADPRibase-Mn was 70% pure,
the purity ratios of the mutants versus the wild type ranged 0.74–1.13. So the minor differences
of purity between some of the mutants and the wild type do not affect to an important extent
the estimation of the shifts of kcat and kcat/Km elicited by the mutations.
Enzyme assays
All the enzyme assays and kinetic studies were as described elsewhere, and were linear with
time and ADPRibase-Mn amount [4, 52]. In summary, phosphohydrolytic reactions were
studied by measuring colorimetrically the Pi liberated by alkaline phosphatase from the reac-
tion products, with the exceptions of the phosphohydrolytic reactions of CDP, CMP, ADP and
AMP, for which the Pi liberated was measured without including alkaline phosphatase in the
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assay, and of cADPR phosphohydrolysis which was studied by following the accumulation of
N1-(5-phosphoribosyl)-AMP by HPLC (see below). Under the standard conditions, the assays
were conducted at 37°C, pH 7.5, and in the presence of 5 mMMnCl2, unless otherwise stated.
Saturation analysis was conducted from initial-rate assays. The kcat and Km values were ob-
tained by nonlinear regression of the Michaelis-Menten equation to the experimental data
points using the Solver tool of the Microsoft Excel 2004 for the Mac version 11.0. In cases
where separate kcat and Km values could not be estimated, the kcat/Km ratio (catalytic efficiency)
was calculated from initial-rate assays at low substrate when velocity is proportional to sub-
strate concentration (S) and the enzyme is largely unbound to substrate. Under these condi-
tions kcat/Km = v/(E S), E being the total enzyme concentration [56].
High performance liquid chromatography
A HP-1100 chromatograph (Hewlett-Packard) was used with a manual injector equipped with
a 20-μl injection loop and a diode array detector. The analyses were performed by ion-pair re-
verse-phase HPLC in a 15 cm x 0.4 cm octadecylsilica column (Kromasil 100; Teknokroma,
Sant Cugat del Vallés, Barcelona, Spain) with a 1 cm x 0.4 cm pre-column of the same material.
The chromatographic conditions for analyses of enzyme reaction products were as described
for the hydrolysis of cADPR [4] or 2´,3´-cAMP [52]. Chromatogram analyses were performed
with the HP ChemStation software.
Sequence analyses
Searches for eukaryotic ADPRibase-Mn homologs were done by BlastP analyses [57], using the
human protein as query, against NCBI_nr or NCBI_RefSeq databases (last access on July 7,
2014) [58]. The former was used to test for the absence of homologous proteins in specific tax-
onomic groups; the latter was mainly used to retrieve a set of representative homologous pro-
teins for sequence alignment. This set of proteins was prepared such that (i) only one protein
per species was included (the one with lower E value when compared with human ADPRibase-
Mn); (ii) proteins with an identity higher than 95% with any other already selected were dis-
carded (in order to avoid overrepresentation of particular taxonomic groups); (iii) proteins
with less than an 80% of query coverage or without the complete MDP-superfamily motif (DX
[H/X]-Xn-GDXX[D/X]-Xn-GNH[D/E]-Xn-[G/X]H-Xn-GHX[H/X] [59–63]) were also dis-
carded. Protein alignments were performed with Clustal Omega [64] using default parameters
and analyzed and colored with ESPript [65].
Homology model of human ADPRibase-Mn
The coordinates of the homology model of human ADPRibase-Mn were downloaded on July
24, 2011 from the SWISS-MODEL repository [53]. This model is based on the known structure
of zebrafish ADPRibase-Mn (Protein Data Bank ID 2NXF), with which the human protein has
66% similarity, including 51% identity. The template and the downloaded model lacked the
fourteen N-terminal and the six C-terminal residues, so to obtain a complete model they were
built with Modeller [66]. The coordinates for the two metal ions and the water molecule coor-
dinated with them were taken from the structure of zebrafish ADPRibase-Mn.
Substrate docking
The model of ADPRibase-Mn and its ligands were prepared for docking as described [2, 4, 52]:
the ligand coordinates were generated with Marvin (Chemaxon), the receptor and the ligands
were prepared for docking with AutoDock Tools [67] and docking calculations were run with
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AutoDock [68]. Two hundred conformations were obtained for each substrate docked, except
that 1000 conformations were obtained for cADPR. For selection of the best docked conforma-
tions, it was hypothesized that the metal-bridging water could act as the attacking nucleophile
over the P atom participating in the substrate scissile bond, like in the mechanisms of other
phosphoesterases [61, 69]. For ADP-ribose, CDP-choline and cADPR, the best conformation
was taken as the one with the lowest energy level among those in which the angle formed by
the O-to-P attack line and the scissile P-O bond was170°. For 2´,3´-cAMP, which posed in
two different orientations favoring either 3´-AMP or 2´-AMP as product, the conformation
chosen had the largest attack angle among those showing the orientation favorable to 3´-AMP
formation. In agreement with the above mentioned hypothesis, one of the substrate P atoms
was at short distance (< 3 Å) of the metal-bridging water oxygen in all the selected conforma-
tions. The coordinates of the four docking complexes with the model structure of human
ADPRibase-Mn are included in S1–S4 Dataset.
Molecular dynamics simulations
The complex of human ADPRibase-Mn with ADP-ribose obtained by docking was the starting
structure for the simulation of molecular dynamics (MD) of the enzyme-substrate complex
and the free enzyme (after ADP-ribose removal). Geometry optimizations and MD simulations
were performed with the GROMACS package (version 4.0.5) [70] in combination with the
GROMOS 53A6 force field [71]. For the simulation of the enzyme-substrate complex, force
field parameters for ADP-ribose were assigned based on analogous functional groups already
present in the force field library. Each system was immersed in a cubic box of SPC water mole-
cules [72] and 50 mMNaCl. The minimum distance between the protein and the walls of the
periodic box was 10 Å. The energy of each system was minimized with 2000–2500 steps of stee-
pest descent algorithm. Equilibration was carried out in three steps: first, 20 ps of constant vol-
ume equilibration were performed at 300 K with position restraints on the protein; second, 200
ps of constant pressure equilibration with position restraints on the protein; third, 100 ps of
constant pressure equilibration without position restraints. Production runs were started at
this point. Bond lengths of protein (and ligand) were constrained with LINCS [73, 74] and
those of water with SETTLE [75], allowing for a 2-fs time step. The non-bonded interactions
were treated with a triple-range schema with cut-off radii of 8 Å and 14 Å. The short-range van
der Waals and electrostatic interactions were evaluated every time step from a pairlist that was
generated every five steps. Medium-range van der Waals and electrostatic interactions (be-
tween 8 Å and 14 Å) were computed every fifth step and kept constant between pairlist up-
dates. Long-range electrostatic interactions outside the longer cut-off were accounted for by a
reaction field with a relative dielectric permittivity of 66. The temperature (300 K) and pressure
(1 atm) were kept constant using the Berendsen thermostat and barostat [76] with τT = 0.1 ps
and P = 0.5 ps, respectively. Coordinates were saved every 1 ps. To help maintaining the geome-
try of the dimetallic center, the distances between the metal ions and the coordinated water
molecule were constrained to their initial distances.
Results and Discussion
Catalytic specificity of human ADPRibase-Mn including cADPR
phosphohydrolase activity
The catalytic specificity of the recombinant protein was as expected for a typical ADPRibase-
Mn [1, 52]. When phosphohydrolytic activities were assayed in the presence of 5 mMMn2+, at
a fixed 500 μM substrate concentration, ADP-ribose was hydrolyzed at the highest rate. The
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CDP-alcohols (CDP-choline, CDP-ethanolamine and CDP-glycerol) followed near at
70%–90% of the ADP-ribose rate. Somewhat slower (40%) was the hydrolysis of 2´,3´-cAMP,
and even slower the reactions of ADP and cADPR. ADP-glucose, UDP-glucose, CDP, CMP,
AMP, 3´,5´-cAMP were not hydrolyzed at detectable rates (< 0.1%). The results are summa-
rized in S3 Table.
The reaction product of 2´,3´-cAMP hydrolysis, assayed by HPLC, was mainly 3´-AMP,
which corresponds to the hydrolysis of the ester linkage on the 2´-O side of the phosphodiester,
although a minor proportion of 2´-AMP was also formed (< 3% of 3´-AMP), like with zebra-
fish ADPRibase-Mn [52]. The product of cADPR hydrolysis, also assayed by HPLC, was
N1-(5-phosphoribosyl)-AMP, which corresponds to the hydrolysis of the phosphoanhydride
linkage of cADPR like with rat ADPRibase-Mn [4].
The responses of activity to varying pH or Mn2+ concentration were studied with ADP-
ribose, CDP-choline and 2´,3´-cAMP. The hydrolysis of ADP-ribose, assayed at pH 6.0–10.5,
showed a symmetrical bell-shaped profile with maximal activity at pH 8.5, whereas the hydro-
lysis of the other substrates showed a rather flat profile at pH 6.0–8.5 followed by a steep de-
crease at higher pH values (S1 Fig.). This behavior is similar to that shown by both the rat and
the zebrafish ADPRibase-Mn [2, 52]. The different pH-activity profiles seem to indicate that
the hydrolysis of ADP-ribose, but not the other substrates, depend on the dissociation of an
acidic group with apparent pKa between 7 and 8. The responses of activity to Mn
2+ were near
complete at about 10 μMmetal and remained essentially without change up to 5 mM (S2 Fig.),
similarly to the rat ADPRibase-Mn [1, 2].
Saturation kinetics at varying concentrations of substrate, with Mn2+ concentration fixed at
5 mM and at pH 7.5, was studied with ADP-ribose, CDP-choline, 2´,3´-cAMP and cADPR.
The best substrate in terms of catalytic efficiency (kcat/Km) was ADP-ribose due to its lower Km
value, followed by CDP-choline, 2´,3´-cAMP and cADPR (Table 1). The phosphoanhydride
linkage of cADPR was hydrolyzed with the same catalytic efficiency as the rat enzyme [4],
i.e. about 4000 M-1s-1, which is at least 150-fold higher than the efficiency of the zebrafish en-
zyme [52]. The difference was due to the much higher kcat values of the mammalian enzymes
for this substrate, compared to the enzyme from the fish. This confirmed that a relatively ro-
bust cADPR phosphohydrolase activity may be a general feature of mammalian ADPRibase-
Mn. In this concern, and as earlier pointed out, a ratio of efficiencies for ADP-ribose/cADPR
hydrolysis near 100 (Table 1 and [4]) is near the ratio of ADP-ribose/cADPR synthesis from
NAD by CD38, the major cADPR-forming enzyme in mammals [15, 18, 20, 77]. Therefore, the
potential of ADPRibase-Mn for cADPR turnover may be relevant.
Reexamination of the taxonomic distribution of the
ADPRibase-Mn-like family
It has been reported that, among animals, the ADPRibase-Mn-like protein family has a phylo-
genetic distribution restricted to vertebrates, although it is present also in plants and algae [2].
This distribution was here reexamined to account for the considerable increase in database size
since that report, and to test the degree of conservation of important residues revealed by the
present study (see below). The results confirmed essentially the above-mentioned distribution
with minor but perhaps important exceptions. ADPRibase-Mn proteins appeared widespread
in vertebrates (possibly also in other Chordata and in Hemichordata) and plants, were absent
from fungi, and irregularly distributed among protists. Concerning invertebrates, significant
ADPRibase-Mn relatives were absent from most taxa, which included those with some organ-
ism(s) with well characterized genomes, like Arthropoda, Echinodermata and Nematoda.
However, there was the important exception of Mollusca, where ADPRibase-Mn-like proteins
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Table 1. Kinetic parameters of human ADPRibase-Mn and mutants.
Mutations Substrate kcat Km kcat/Km
s-1 Fold change µM Fold change M-1s-1 Fold change
Wild type ADP-ribose 35 ± 11 – 60 ± 8 – 590000 ± 160000 –
CDP-choline 50 ± 4 – 350 ± 60 – 150000 ± 30000 –
2´,3´-cAMP 60 ± 13 – 2400 ± 300 – 25000 ± 6000 –
cADPR 3.2 ± 0.2 – 780 ± 200 – 4000 ± 1000 –
Q27H ADP-ribose 10 ± 3 #4 200 ± 14 "3 52000 ± 10000 #11
CDP-choline 39 ± 12  2700 ± 200 "8 14000 ± 3000 #11
2´,3´-cAMP 4.3 ± 1.1 #14 2300 ± 130  1900 ± 400 #13
cADPR na na na na 150 ± 20 #27
F37A ADP-ribose 14 ± 3 #3 1150 ± 80 "19 12000 ± 2000 #50
CDP-choline 33 ± 7 #1.5 970 ± 140 "3 34000 ± 3000 #4
2´,3´-cAMP 36 ± 6 #1.7 5100 ± 300 "2 7000 ± 700 #4
cADPR na na na na 1300 ± 200 #3
F37Y ADP-ribose 50 ± 11  77 ± 10  650000 ± 170000 
CDP-choline 76 ± 23  430 ± 50  180000 ± 60000 
2´,3´-cAMP 70 ± 18  2500 ± 180  28000 ± 5000 
cADPR na na na na 4100 ± 100 
R43A ADP-ribose 0.003 ± 0.003 #12000 115 ± 30 "1.9 30 ± 30 #20000
CDP-choline 0.025 ± 0.004 #2000 9000 ± 8000 "26 6 ± 6 #25000
2´,3´-cAMP 0.95 ± 0.14 #60 7600 ± 1900 "3 130 ± 20 #200
cADPR na na na na 0.1 ± 0.1 #40000
N110A ADP-ribose 4.3 ± 0.6 #8 290 ± 50 "5 15000 ± 200 #40
CDP-choline 5.7 ± 1.4 #9 4000 ± 1100 "11 1500 ± 400 #100
2´,3´-cAMP 0.11 ± 0.01 #550 1050 ± 60 #2 100 ± 10 #250
cADPR na na na na 130 ± 30 #31
H111A ADP-ribose 0.47 ± 0.08 #75 140 ± 14 "2 3000 ± 200 #200
CDP-choline 2.2 ± 0.2 #23 7500 ± 700 "21 300 ± 30 #500
2´,3´-cAMP 7.4 ± 2.9 #8 1250 ± 450 #2 6000 ± 400 #4
cADPR na na na na 70 ± 6 #60
H111N ADP-ribose 2.3 ± 0.2 #15 78 ± 5  29000 ± 4000 #20
CDP-choline 5.3 ± 1.0 #9 2700 ± 500 "8 2000 ± 400 #75
2´,3´-cAMP 34 ± 6 #1.8 1800 ± 450  19000 ± 2000 
cADPR na na na na 290 ± 40 #14
L196A ADP-ribose 16 ± 4 #2 130 ± 5 "2 120000 ± 30000 #5
CDP-choline 29 ± 13 #1.7 470 ± 90  62000 ± 20000 #2
2´,3´-cAMP 30 ± 10 #2 3400 ± 500  9000 ± 4000 #3
cADPR na na na na 900 ± 100 #4
F210A ADP-ribose 19 ± 3 #1.8 2100 ± 100 "34 9000 ± 1000 #70
CDP-choline 50 ± 12  11000 ± 2600 "32 4000 ± 100 #40
2´,3´-cAMP 2.7 ± 0.2 #22 7600 ± 1700 "3 400 ± 10 #60
cADPR na na na na 8 ± 1 #500
C253A ADP-ribose 97 ± 8 "3 94 ± 6 "1.6 1000000 ± 100000 "1.7
CDP-choline 79 ± 7 "1.6 500 ± 70  160000 ± 20000 
2´,3´-cAMP 83 ± 5  2600 ± 250  32000 ± 2000 
cADPR 8.9 ± 0.8 "3 200 ± 40 #4 44000 ± 9000 "11
(Continued)
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seem to occur in Gastropoda (Aplysia californica and Lottia gigantea) and Bivalvia (Crassostrea
gigas). A significant homolog was also found in Annelida (Helobdella robusta). Of course, it re-
mains to be seen whether these proteins have ADPRibase-Mn enzyme activities. A summary of
the current view of this protein family is shown in S3 Fig. under the form of a
sequence alignment.
Identification of amino acids interacting with ADP-ribose in the model
structure of the enzyme-substrate complex and their relationship to
defined regions of human ADPRibase-Mn
The ADPRibase-Mn family contains the disperse motif of the MDP superfamily that responds
to the description DX[H/X]-Xn-GDXX[D/X]-Xn-GNH[D/E]-Xn-[G/X]H-Xn-GHX[H/X], i.e.
five short consensus regions separated by long tracts (Xn) of nonconserved sequence that, how-
ever, form a well conserved structure. The five short conserved regions are marked in Fig. 1,
Fig. 2 and S3 Fig. They are part of loops located at the end of β strands and contains the amino
acids that form the dinuclear center by coordination to the metals [59–63]. Other than the
MDP superfamily motif, very little sequence conservation is found when the ADPRibase-Mn-
like family is compared to the other eleven MDP families classified in SCOP2. However, there
is ample and strong conservation of structure throughout the superfamily. Against this back-
ground, three structural elements stand out as unique to the ADPRibase-Mn-like family: using
the numbering of zebrafish protein sequence, they correspond approximately to amino acids
20–35, 65–70 and 150–195 [52]. These will be here named, respectively, regions s2s3, h2, and
h7h8, according to the secondary structure elements (s, strand; h, helix) of zebrafish ADPRi-
base-Mn that they contain. These unique regions delimit the entrance to the active site of zeb-
rafish ADPRibase-Mn and of the homology models for which it served as template. They are
present throughout the ADPRibase-Mn-like family with a significant degree of sequence con-
servation (S3 Fig.), and they are candidates to contain substrate specificity determinants.
Table 1. (Continued)
Mutations Substrate kcat Km kcat/Km
s-1 Fold change µM Fold change M-1s-1 Fold change
F37A+L196A ADP-ribose 7 ± 2 #5 1150 ± 500 "19 6000 ± 2000 #100
CDP-choline 25 ± 5 #2 1250 ± 250 "4 21000 ± 8000 #7
2´,3´-cAMP 19 ± 2 #3 4800 ± 900 "2 4000 ± 1000 #6
cADPR na na na na 900 ± 100 #4
F37A+L196F ADP-ribose 8 ± 1 #4 1600 ± 100 "26 4800 ± 200 #120
CDP-choline 26 ± 3 #1.9 1500 ± 250 "4 17000 ± 3000 #9
2´,3´-cAMP 28 ± 3 #2 7100 ± 650 "3 3900 ± 400 #6
cADPR na na na na 1600 ± 200 #3
F37A+L196F+C253A ADP-ribose 13 ± 1 #3 1200 ± 230 "20 11000 ± 1700 #50
CDP-choline 37 ± 5  1700 ± 120 "5 22000 ± 2600 #7
2´,3´-cAMP 20 ± 3 #3 5200 ± 1000 "2 4000 ± 800 #6
cADPR 16 ± 3 "5 460 ± 120 #1.7 35500 ± 4300 "9
The values with S.D. are averages of at least three experiments. Fold change was calculated with respect to the parameters of the wild type. , change <
1.5 fold; na, not assayed (in these cases kcat/Km was calculated from initial-rate assays at low substrate when velocity was proportional to substrate
concentration; see under Materials and Methods).
doi:10.1371/journal.pone.0118680.t001
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To simulate the binding of substrates to human ADPRibase-Mn, a homology model, based
on the known structure of zebrafish ADPRibase-Mn, was taken from a public repository and
completed as described under Materials and Methods. It displayed a deep pocket with a dinuc-
lear center in the bottom and a metal-bridging water. Around the pocket entrance stood the
unique regions s2s3, h2, and h7h8 (Fig. 1). ADP-ribose, cADPR, CDP-choline and 2´,3
´-cAMP were independently docked to this site (S4 Fig.).
The conformation of ADP-ribose docked to the model of human ADPRibase-Mn is shown
in Fig. 2, which displays also the amino acids that interact with ADP-ribose as identified by
analysis with VMD. This included amino acids belonging (i) to the ADPRibase-Mn-unique re-
gions s2s3 (Phe37 and Arg43) or h7h8 (Phe210), (ii) to the MDP superfamily motif (Gln27,
Asn110 and His111), or (iii) to the short h10 helix (Cys253). These seven amino acids interact
also with ADP-ribose docked to a homology model of rat ADPRibase-Mn [2]. Their locations
in human ADPRibase-Mn are highlighted in Fig. 1, as it is the position of Leu196 within h7h8
because, although it did not interact with ADP-ribose docked to human ADPRibase-Mn, it
does so with the substrate docked to rat ADPRibase-Mn [2]. These eight amino acids of the
human enzyme were subjected to mutagenesis.
Point mutations in human ADPRibase-Mn and effects on kinetic
parameters
Most of the mutations implemented were intended to inactivate a potential effect of the inter-
acting amino acid, and the native residues were changed to alanine (some control mutations
Fig 1. Stereogram of the model structure of human ADPRibase-Mn. Schematic model without substrate, showing metals (golden spheres), metal-
bridging water (red sphere), the five short consensus regions of the MDP-superfamily motif (violet), and the ADPRibase-Mn unique regions s2s3 (green), h2
(yellow), and h7h8 (orange). The amino acids chosen for mutagenesis are highlighted and colored by residue: Gln27 (orange), Phe37 (magenta, in s2s3),
Arg43 (red), Asn110 (pink), His111 (cyan), Leu196 (blue), Phe210 (magenta; in h7h8) and Cys253 (yellow). The model is based, as indicated in Materials and
Methods, in the structure of the zebrafish homolog (PDB ID 2NXF).
doi:10.1371/journal.pone.0118680.g001
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were performed to non-alanine residues). The only exception was the mutation of Gln27,
aimed to test the effects of its substitution by a histidine residue, which is present in other
MDP proteins.
The effects of the mutations were tested by kinetic assay of kcat, Km and kcat/Km with ADP-
ribose, CDP-choline, 2´,3´-cAMP and cADPR. With the latter substrate, in many cases, rather
than measuring kcat and Km from saturation curves, the catalytic efficiency parameter kcat/Km
was directly estimated under conditions of rate linearity versus cADPR concentration, i.e. at
cADPR concentrations well below the Km value [4, 52, 56]. The results are summarized in
Table 1.
The majority of the mutations to alanine of the amino acids interacting with ADP-ribose di-
minished the catalytic efficiency for this substrate to different extents. Sometimes, but not al-
ways, roughly similar decreases of efficiency were observed with the other substrates. However,
an important exception was the absence of negative effect of mutating Cys253 which, as stated
above, was the only residue unrelated to the disperse motif of the MDP superfamily and to the
regions unique to the ADPRibase-Mn-like family. Actually, the C253A mutant displayed a ten-
fold increased efficiency over cADPR, with no or modest effect on the other substrates. The
meaning of these and other results of the mutagenesis study, which included a few double and
one triple mutant, is presented and discussed below in detail.
Roles of amino acids belonging to the disperse motif of the MDP
superfamily: Gln27, Asn110 and His111
Three of the amino acids that have been mutated in human ADPRibase-Mn belong to two of
the short consensus regions of the MDP superfamily motif.
Fig 2. Stereogram of ADP-ribose docked to the active site of the model structure of human ADPRibase-Mn: identification of interacting amino
acids. Besides ADP-ribose, the model shows the dimetallic center bound to the five short consensus regions of the MDP-superfamily motif (I-V, violet), and
the amino acids identified by their interaction with docked ADP-ribose (see the main text for details). This set of hypothetic interactions was the starting point
for the mutagenesis experiments. The conformation shown in the figure was the starting structure for the molecular dynamics simulation of the enzyme-
substrate complex (Fig. 3).
doi:10.1371/journal.pone.0118680.g002
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Gln27 occupies the third position of the first consensus region (DX[H/X]), that in the
ADPRibase-Mn-like family is conserved as D[V/I]Q with very few exceptions (see S3 Fig.). In
the docking model with ADP-ribose, the carbonyl group of Gln27 side chain is coordinated
with one of the metal ions (metal 1), and the amide NH2 is near to form a hydrogen bond with
one of the oxygens of the β phosphate of ADP-ribose. We chose to implement the Q27H muta-
tion that does not eliminate the possibility of side-chain interactions and converts the D[V/I]Q
region to D[V/I]H that is the more general consensus of the MDP superfamily [59–63]. The
mutation did not change the relative preference of the enzyme for the four substrates consid-
ered as it reduced to the same extent (11–13-fold reduction) the catalytic efficiency of the
hydrolysis of ADP-ribose, CDP-choline or 2´,3´-cAMP, and only somewhat more strongly
(27-fold reduction) the hydrolysis of cADPR (see Table 1). However, the effects on kcat and
Km differed among the three first substrates. The kcat value diminished 4 fold for ADP-ribose,
was unchanged for CDP-choline and diminished 14 fold for 2´,3´-cAMP. The Km value aug-
mented 3 fold for ADP-ribose, 8 fold for CDP-choline and did not change for 2´,3´-cAMP.
There was no data available on kcat and Km for cADPR. In summary, for ADP-ribose, the
Q27H substitution elicited modest negative effects of similar magnitude in catalysis and in sub-
strate binding. For CDP-choline, the substitution did not affect catalysis, only binding. On the
contrary, for 2´,3´-cAMP, the substitution affected catalysis not binding, perhaps because the
larger size of histidine made less likely for this substrate to adopt a favorable orientation of the
scissile P-O bond with respect to the water nucleophile.
Asn110 is part of the GNH[D/E] consensus region as an invariant residue (S3 Fig.). In the
docking model with ADP-ribose, the side-chain carbonyl of Asn110 is coordinated with one of
the metal ions (metal 2) and its amide NH2 is donor in a hydrogen bond with one of the oxy-
gens of the phosphate of ADP-ribose. We chose to implement in this case a N110A mutation
that might affect both the coordination sphere of the dinuclear center and the binding of sub-
strate. The effects of this substitution on kinetic parameters (Table 1) showed a complex re-
sponse that partly recalled the effects of the Q27H mutation but with a few important
differences. First, with the N110A substitution the reduction of catalytic efficiency was stronger
(100–250 fold) for the hydrolysis of CDP-choline or 2´,3´-cAMP than for the hydrolysis of
ADP-ribose or cADPR (30–40 fold). The decrease of kcat value was stronger for the hydrolysis
of 2´,3´-cAMP which was 550 fold smaller than the wild type kcat. The changes of Km were little
different to those elicited by the Q27H substitution. The results of this mutation are difficult to
interpret as, besides the possible effects on the metal coordination sphere and on the binding of
substrate, the proximity of Asn110 to His111 could affect the interaction of the latter with sub-
strates (see below).
His111 is also an invariant residue of the GNH[D/E] consensus like Asn110 (S3 Fig.), and in
non-ADPRibase-Mn MDPs it has been found important in catalysis but not involved in metal
coordination [78–81]. In ADPRibase-Mn, the GNH[D/E] histidine residue is neither involved
in metal coordination, but is at hydrogen bond distance of the phosphoanhydride oxygen of di-
phosphate substrates or of the 2´-phosphoester of 2´,3´-cAMP (S4 Fig.). This has been ob-
served also in docking complexes of zebrafish ADPRibase-Mn [52]. We implemented two
His111 mutants: H111A and H111N. The first one caused a marked efficiency decrease with all
substrates except 2´,3´-cAMP, which was little affected. The same response pattern was pro-
duced by the equivalent mutation in zebrafish ADPRibase-Mn [52]. These results support the
previously suggested role of this histidine residue in catalysis through an orientation effect aug-
menting the probability of a near in-line attack of the metal-bridging water over the P-O scis-
sile bond [52, 80]. The action of the GNH[D/E] histidine of ADPRibase-Mn as a general acid
catalyst seems unlikely in view of the modest or null effect of the mutation on the kinetic pa-
rameters of the hydrolysis of the 2´,3´-cAMP phosphodiester, as opposed to the strong effect
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on the hydrolysis of the phosphoanhydride linkage of the other substrates (Table 1, and [52]).
The importance of general acid catalysis should be, if something, more obvious for the hydroly-
sis of a phosphodiester than a phosphoanhydride, as the former would profit from a proton
donor to yield an alcohol leaving group. A similar reasoning can be made from the results of
the H111N mutation, as being the asparagine side chain unable to act as general catalyst, the re-
sults of this substitution did neither affect the kinetic parameters of 2´,3´-cAMP phosphodie-
ster hydrolysis. On the other hand, concerning the possible orientation effect, the (near)
independence of 2´,3´-cAMP hydrolysis on the GNH[D/E] histidine would be explainable by
the structural rigidity of this substrate and its straightforward fit in the active site with the in-
line orientation [52].
The unique structural element s2s3 in human ADPRibase-Mn:
catalytic role of Arg43 and role of Phe37 in the enzyme preference
for ADP-ribose
In the human ADPRibase-Mn, the unique region s2s3 is formed by amino acids 30–45 (S5
Fig.). From the mutagenesis experiments, the two s2s3 amino acids that interacted with ADP-
ribose, Arg43 and Phe37, emerged as critically relevant to the catalytic mechanism or
the specificity.
The sidechain of Arg43 points towards the pyrophosphate groups of ADP-ribose (Fig. 2)
and probably of the other docked substrates (S4 Fig.). This residue is invariant in the ADPRi-
base-Mn-like family (S3 Fig.), and it could have a role in stabilizing the transition state and or
the leaving group. In agreement with this catalytic role, the R43A mutant showed a drastic,
four-orders-of-magnitude decrease of catalytic efficiency (kcat/Km) with all the substrates ex-
cept 2´,3´-cAMP, for which only a 200-fold decrease of efficiency was observed (Table 1). This,
though quite strong an effect, indicates, together with the modest or null effects of His111 muta-
tions, that the catalytic requirements for the hydrolysis of 2´,3´-cAMP by human ADPRibase-
Mn are lesser than for the other substrates (see above: Table 1 and [52]).
In the hypothetical conformation adopted by ADP-ribose in the docking model, the hydro-
phobic ring of Phe37 made a contact with the nitrogenous base, which was not observed with
the other docked substrates (S4 Fig.). Since the ADPRibase-Mn preference for ADP-ribose was
characterized by a considerably lower Km when compared to the other substrates (Table 1), the
potential specificity of the interaction with Phe37 suggested that this amino acid could be a de-
terminant for the ADP-ribose preference. In agreement with this view, the F37A mutant dis-
played a 19-fold increased Km for ADP-ribose, with only a 2–3-fold increase of the CDP-
choline and 2´,3´-cAMP Km values. At the same time only minor decreases of kcat were elicited
by the same mutation. In terms of kcat/Km, the F37A mutation diminished the efficiency of
ADP-ribose hydrolysis by 50 fold, but that of the other substrates, including cADPR, was re-
duced by only 3–4 fold. The control mutant F37Y showed the same kinetic parameters as the
wild type. In summary, the preferred substrate of F37A-ADPRibase-Mn was CDP-choline, in-
dicating that the preference of wild type ADPRibase-Mn by ADP-ribose is determined by
Phe37. This residue is widely conserved as phenylalanine or tyrosine, in animals and plants
with some substitutions by aliphatic amino acids in protist ADPRibase-Mn proteins (S3 Fig.).
It would be interesting to learn the natural specificity of proteins of this family having Phe37 re-
placed by a nonaromatic residue.
Additional support for the interaction of ADP-ribose with Phe37 within s2s3 came from
simulations of molecular dynamics (see below).
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Effects of docked ADP-ribose on the simulated molecular dynamics of
the ADPRibase-Mn model
To search for possible effects of the binding of ADP-ribose to the active site of human ADPRi-
base-Mn, 40-ns simulations of molecular dynamics of the ADPRibase-Mn:ADP-ribose model
obtained by docking, and of the free enzyme, were run and compared (Fig. 3). In the dynamic
trajectory, four protein regions showed a substrate-dependent decrease of mobility, one of
them apparently related to the proximity of bound ADP-ribose. The mobility of the backbone
C atoms was quantitated by measuring their root mean square fluctuations (RMSF) along the
trajectories, which identified the regions of diminished mobility as those formed by amino
acids 7–14, 34–41, 78–84 and 333–342. The first and the last of those regions correspond to the
polypeptide ends. Interestingly, region 34–41 is included in s2s3 (amino acids 30–45) and re-
gion 78–84 coincides well with h2 (amino acids 78–85), which have been identified as regions
unique to the ADPRibase-Mn-like family (Fig. 1, S5 Fig. and [52]). On the other hand, region
h7h8 (amino acids 170–212), also unique to this family, showed high mobility in its central
part (amino acids 175–205) but was little affected by the presence of bound ADP-ribose in the
simulation (Fig. 3).
In summary, the decreased mobility of the s2s3 element (which contains the ADP-ribose-
specificity determinant Phe37) in the presence of docked ADP-ribose, supports the importance
of the interaction of the substrate with the amino acid.
The unique structural element h7h8 in human ADPRibase-Mn:
relevance of Leu196 and Phe210
The unique structural element h7h8 of human ADPRibase-Mn is formed by amino acids
170–212 (S5 Fig.). Within it, we focused on Leu196 and Phe210. To judge from single-point mu-
tations, only the latter had a clearcut repercussion over enzyme action. However, some rele-
vance of Leu196 was inferred from the analysis of double mutants.
Leu196 is conserved in vertebrates but not in most of the ADPRibase-Mn proteins belonging
to other taxa (S3 Fig.). This amino acid is located approximately opposite the specificity deter-
minant Phe37, not very far from it across the entrance to the active site (Fig. 1). Together, these
two amino acids could favor a closed conformation of the active site. In a docking model of
ADP-ribose with rat ADPRibase-Mn, Leu196 is close to the adenine ring [2], but a similar con-
tact was not seen in the docking complex with the modeled human enzyme (Fig. 2). However,
mutagenesis of Leu196 had interesting if subtle effects. The L196A point mutation caused only a
modest 2–5-fold decrease of catalytic efficiency with the four substrates tested. The F37A
+L196A double mutant showed a modest enhancement of the inhibitory effect over that of the
F37A point mutation. Unexpectedly, such effect was even slightly stronger with the control
double mutation F37A+L196F, except for the activity on cADPR, which was less affected than
by F37A+L196A (Table 1). The effect of Leu196 mutagenesis is best illustrated by the ratio of
catalytic efficiencies ADP-ribose/cADPR: 150 for the wild type; 9.2 for F37A; 6.7 for F37A
+L196A; 3.0 for F37A+L196F. The minor effect of the Leu196 substitutions, that favored the
cADPR phosphohydrolase activity in relative terms, was taken to advantage, in a synergistic
combination with the C253A mutation, to obtain an ADPRibase-Mn triple mutant that dis-
played preferential activity on cADPR (see below).
The sidechain of Phe210, which is widely conserved in the ADPRibase-Mn family (S3 Fig.),
lays beside the substrate, near the pyrophosphate and the two riboses in the docking model
with ADP-ribose, acting perhaps as a stanchion that keeps the substrate into position (Fig. 2).
Its relevance was supported by the effects of the F210A mutation, which lowered 40–70 fold
the catalytic efficiency for ADP-ribose, CDP-choline and 2´,3´-cAMP hydrolysis, and 500 fold
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for cADPR (Table 1). The decrease of kcat/Km was due to increases of Km for ADP-ribose and
CDP-choline, with little effect on kcat values, but mainly to a decrease of kcat for 2´,3´-cAMP.
The different response of the latter to the F210A mutation could be related to the rigidity of 2
´,3´-cAMP and to a lower probability of adopting a conformation with the scissile P-O bond in
line with the water nucleophile in the absence of the phenyl group of Phe210. The more flexible
structures of ADP-ribose and CDP-choline, though binding with lower affinities in the absence
of the aromatic ring of Phe210, would then be as likely to adopt the conformation favorable to
the nucleophilic attack as when bound to the wild-type enzyme.
Fig 3. Molecular dynamics simulation of the complex of modeled human ADPRibase-Mn with ADP-ribose, and its comparison to the substrate-free
enzyme. Simulations of 40 ns were implemented as described under Materials and Methods. The upper protein models show the overlap of 40 snapshots
taken at 1-ns intervals, with the protein backbone represented as a thin tube colored by mobility (red, maximal mobility; blue minimal mobility). The left-hand
side and the right-hand side models contain the dimetallic center and the bridging water, and the right-hand side one contains also docked ADP-ribose
colored by element. These ligands are shown in the positions occupied at the beginning of the simulations. The lower graph shows the mobility of the Cα
atoms of the protein backbone quantitated as RMSF values.
doi:10.1371/journal.pone.0118680.g003
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Role of Cys253 as a factor limiting the cADPR phosphohydrolase activity
of ADPRibase-Mn
Most of the mutations tested either diminished the catalytic efficiency of cADPR phosphohy-
drolase or elicited only modest changes, more or less in parallel to changes of efficiency on the
other substrates considered (Table 1). Anyhow, there were two important exceptions to this
general trend. One was observed in the effects of the F37A mutation which, as discussed below,
revealed Phe37 is a major determinant of the preference of ADPRibase-Mn for ADP-ribose as
substrate, with a comparatively minor effect on the hydrolysis of the other substrates, cADPR
included. The other exception, more relevant to the character of the cADPR phosphohydrolase
activity, was the effect of the C253A mutation, which unexpectedly elicited a specific increase
(10 fold) of the catalytic efficiency over cADPR, composed by a decrease of the Km (to a value
similar to those of the rat and the zebrafish enzymes), and an increase of kcat. In comparison,
the removal of the thiol group of Cys253 did not affect or caused a very slight increase of the ap-
parent affinity of the enzyme for the other substrates. It seems that this residue hinders the op-
timal binding of cADPR to the active site of human ADPRibase-Mn.
Cys253 is extensively conserved among vertebrates, but not in ADPRibase-Mn-like proteins
of other taxa in which the family is present (S3 Fig.). Whether non-vertebrate enzymes, partic-
ularly those of higher plant origin in which alanine occupies naturally the position equivalent
to human Cys253, could be better cADPR phosphohydrolase catalysts than mammalian
ADPRibase-Mn remains speculative.
Construction of a triple mutant preferentially active on cADPR
As a proof of principle that the specificity for cADPR can be augmented by mutagenesis, the
triple ADPRibase-Mn mutant F37A+L196F+C253A was constructed. In it, the double muta-
tion F37A+L196F, which had been shown to lessen the relative preference for ADP-ribose ver-
sus cADPR, was combined with the specific activation of cADPR phosphohydrolase produced
by the C253A mutation in absolute terms. Had this combination produced additive effects, one
would expect that the resulting protein displayed a ratio of catalytic efficiencies cADPR/ADP-
ribose about 2. In fact, the kinetic characterization of the triple mutant gave a kcat/Km value of
35500 M-1s-1, 3.2-fold higher than the efficiency of ADP-ribose hydrolysis, and also higher
than those of CDP-choline and 2´,3´-cAMP (Table 1). The kcat/Km values for other ADPRi-
base-Mn substrates not included in the kinetic study of mutants were also assayed with the tri-
ple mutant to proof that they were also lower than with cADPR, namely CDP-glycerol, 22000
± 4000 M-1s-1; CDP-ethanolamine, 5800 ± 700 M-1s-1; ADP, 53 ± 12 M-1s-1.
Concluding discussion
First, we would like to emphasize that the structural and dynamic information on human
ADPRibase-Mn presented in this study comes from homology modeling and simulation stud-
ies of docking and molecular dynamics. The strength of this approach is not comparable to
what NMR or X-ray studies of actual structures and interactions would afford. In particular,
one has to be aware that the docking itself produces speculative information and may give false
positives. Therefore, data relative to interactions, positions, angles or distances measured on
the human ADPRibase-Mn models should be taken as hypothetical. We have used these data
as starting point to choose residues for mutation, and as arguments to help in the interpretation
of the kinetic behavior of mutant proteins.
The dinuclear center of the crystal structure of zebrafish ADPRibase-Mn contains a metal-
bridging molecule of water that was included in the homology model of the human enzyme to
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which the substrates were docked. Based mainly on the docking of ADP-ribose to this model,
eight amino acids of human ADPRibase-Mn were selected for mutagenesis. To analyze the re-
sults of the mutagenesis and enzyme kinetics studies, it was hypothesized that the bridging
metal-activated water or hydroxide could be the attacking nucleophile like in the mechanisms
of other phosphoesterases [61, 69]. According to this model, substrates need correct position-
ing in the active center for the attack to be made under near in-line conditions. Another mech-
anistic aspect here considered is the possible stabilization of the transition state of the reactions
by charge neutralization.
Several ADPRibase-Mn amino acids with roles in catalysis and/or substrate specificity have
been identified in this study. In many cases, the kinetic effects of a particular mutation were dif-
ferent depending on the substrate considered. A corollary of this picture is that the correct po-
sitioning of each substrate may depend, more or less strictly, on a different set of amino acids.
Not surprisingly, substrate-positioning residues may have bearing both on catalysis (kcat) and
substrate binding (Km).
Two amino acids appeared clearly involved in catalysis. (i) Arg43, due to the proximity of its
sidechain end to the substrate phosphoryl group(s), probably stabilizes the transition state and/
or the leaving group by charge neutralization. Comparing the hydrolytic reactions with differ-
ent substrates, the bearing of Arg43 on catalysis was less dramatic (but quite strong at any rate)
for the hydrolysis of 2´,3´-cAMP, perhaps because of the single phosphoryl group, and the rela-
tively low activation energy of hydrolysis of its P-O2´ ester linkage [82]. (ii) His111, that may
form a hydrogen bond with the O atom of the scissile P-O bond, probably helps to keep the
substrate in a position susceptible of in-line nucleophilic attack by the metal-activated water.
Again, the bearing of His111 on catalysis was less marked with 2´,3´-cAMP as the substrate. As
a consequence, this was the best substrate for the H111A-ADPRibase-Mn mutant. A similar ef-
fect of the equivalent residue and mutation, observed with zebrafish ADPRibase-Mn, has been
attributed to the low conformational flexibility of this compound and to its lesser need of assis-
ted orientation towards the in-line position [52]. Another substrate-specific effect of His111
concerned substrate binding, since its mutation increased the Km for CDP-choline, but not for
the other substrates.
Another two residues appeared clearly involved in substrate specificity. (i) Phe37 is located
in the rim of the entrance to the active site, distant from the catalytic core around the dinuclear
center. In such position, Phe37 acts as the determinant of the ADPRibase-Mn preference for
ADP-ribose, possibly due to a specific interaction of the aromatic residue with the
nitrogenous base of ADP-ribose. The other substrates do not seem to make this contact in
their docking models. The larger observed effect of the F37A mutation was the increase of the
Km for ADP-ribose, with only modest effects on the kcat values or on the Km s for CDP-choline
and 2´,3´-cAMP. Therefore, the best substrate of the F37A mutant was no longer ADP-ribose,
but CDP-choline. (ii) Cys253 is located near the catalytic core and the dinuclear center, without
evidence for interaction with the metals. The SH group is at near contact distance with the C3
of the non-nucleosidic ribose of ADP-ribose or the “northern” ribose of cADPR. Interestingly,
this does not seem to be a favorable contact, but a subtle obstacle to optimal cADPR binding
and positioning, thus limiting the phosphohydrolytic activity on this substrate. The C253A
mutation elicited modest but favorable effects both in kcat and Km for cADPR, what brought
about a significant and unique increase in catalytic efficiency on this substrate. This was the
only point mutation bringing about an efficiency increase. Two other mutations together
(F37A and L196A), although eliciting negative effects in absolute terms, affected less the hydro-
lysis of cADPR than of other substrates. The result of combining the three mutations (F37A
+L196F+C253A) was an ADPRibase-Mn protein that acted preferentially as
cADPR phosphohydrolase.
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In summary, this work sheds light on the mechanism and specificity of human ADPRibase-
Mn and paves the way for identifying more specific cADPR phosphohydrolases, perhaps
among ADPRibase-Mn-like proteins in which Cys253 is not conserved, and/or for designing
ADPRibase-Mn mutants with such specificity. This future goal could be compared to the re-
ported conversion of CD38 by mutagenesis from a predominant NAD glycohydrolase to a spe-
cific ADP-ribosyl cyclase [83]. A specific cADPR phosphohydrolase would make a useful tool
for in vitro analytical and in vivo functional studies of this regulator.
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